Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Claims Guidant For $23.9 Bil., Forms CV Device Group Under Valeriani

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson's willingness to pay $24 bil. (6.5-times revenue) for Guidant validates the long-standing claim of ICD manufacturers that the cardiac rhythm management market is largely underserved

You may also be interested in...



J&J/Guidant To Divest Peripheral Devices To Meet EC Competition Rules

Johnson & Johnson has agreed to divest Guidant's European peripheral stent business as a condition of the European Commission's approval of the planned acquisition

J&J/Guidant To Divest Peripheral Devices To Meet EC Competition Rules

Johnson & Johnson has agreed to divest Guidant's European peripheral stent business as a condition of the European Commission's approval of the planned acquisition

J&J May Seek Better Deal For Guidant After ICD Recalls Lower Stock Price

Johnson & Johnson will likely ask Guidant to lower its acquisition price by roughly $2 bil. after recent ICD recalls pushed Guidant's stock price down approximately 10%

Related Content

UsernamePublicRestriction

Register

MT021346

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel